Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer

被引：23

作者：

Yang, Guoliang ^{[1
]}

Bondaruk, Jolanta ^{[1
]}

Cogdell, David ^{[1
]}

Wang, Ziqiao ^{[2
]}

Lee, Sangkyou ^{[1
]}

Lee, June Goo ^{[1
]}

Zhang, Shizhen ^{[1
]}

Choi, Woonyoung ^{[3
]}

Wang, Yan ^{[1
]}

Liang, Yu ^{[1
]}

Wang, Gang ^{[1
]}

Wang, Ying ^{[2
]}

Yao, Hui ^{[4
]}

Dadhania, Vipulkumar ^{[1
]}

Gao, Jianjun ^{[5
]}

Logothetis, Christopher ^{[5
]}

Siefker-Radtke, Arlene ^{[5
]}

Kamat, Ashish ^{[6
]}

Dinney, Colin ^{[6
]}

Theodorescu, Dan ^{[7
]}

Kimmel, Marek ^{[8
]}

Wei, Peng ^{[2
]}

Guo, Charles C. ^{[1
]}

Weinstein, John N. ^{[4
]}

McConkey, David J. ^{[3
]}

Czerniak, Bogdan ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[3] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA

[7] Cedars Sinai, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA

[8] Rice Univ, Dept Stat, Houston, TX 77251 USA

来源：

ISCIENCE | 2020年 / 23卷 / 06期

关键词：

EPITHELIAL-MESENCHYMAL TRANSITION; INFILTRATING IMMUNE CELLS; MOLECULAR CLASSIFICATION; LUMINAL SUBTYPES; CARCINOMA; BREAST; EXPRESSION; BASAL; IDENTIFICATION; DYSREGULATION;

D O I：

10.1016/j.isci.2020.101201

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

We report a comprehensive molecular analysis of 34 cases of small cell carcinoma (SCC) and 84 cases of conventional urothelial carcinoma (UC), with The Cancer GenomeAtlas cohort of 408 conventional UCbladder cancers used as the reference. SCCs showed mutational landscapes characterized by nearly uniforminactivation of TP53 and were dominated by Sanger mutation signature 3 associated with loss of BRCA1/2 function. SCCs were characterized by downregulation of luminal and basal markers and were referred to as double-negative. Transcriptome analyses indicated that SCCs displayed lineage plasticity driven by a urothelial-to-neural phenotypic switch with a dysregulated epithelial-to-mesenchymal transition network. SCCs were depleted of immune cells, and expressed high levels of the immune checkpoint receptor, adenosine receptor A2A(ADORA2A), which is a potent inhibitor o fimmune infiltration. Our observations have important implications for the prognostication and development of more effective therapies for this lethal bladder cancer variant.

引用

页数：35

共 50 条

[21] NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer
Yang, Meihua
Wang, Bo
Hou, Weibin
Zeng, Honghui
He, Wang
Zhang, Xin-Ke
Yan, Dong
Yu, Hao
Huang, Long
Pei, Lu
Li, Kaiwen
Qin, Haide
Lin, Tianxin
Huang, Jian
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07) : 1 - 23
[22] CRACD/ KIAA1211 loss drives cell plasticity and immune evasion of small cell lung cancer
Zhang, Shengzhe
Kim, Kee-Bum
Huang, Yuanjian
Kim, Dong-Wook
Kim, Bongjun
Ko, Kyung-Pil
Zou, Gengyi
Zhang, Jie
Jun, Sohee
Kirk, Nicole A.
Hwang, Ye Eun
Ban, Young Ho
Chan, Joseph M.
Rudin, Charles M.
Park, Kwon-Sik
Park, Jae-Il
CANCER RESEARCH, 2023, 83 (07)
[23] Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer
Minal Garg
Cancer and Metastasis Reviews, 2015, 34 : 691 - 701
[24] Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer
Garg, Minal
CANCER AND METASTASIS REVIEWS, 2015, 34 (04) : 691 - 701
[25] Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer
Guo, Charles C.
Majewski, Tadeusz
Zhang, Li
Yao, Hui
Bondaruk, Jolanta
Wang, Yan
Zhang, Shizhen
Wang, Ziqiao
Lee, June Goo
Lee, Sangkyou
Cogdell, David
Zhang, Miao
Wei, Peng
Grossman, H. Barton
Kamat, Ashish
Duplisea, Jonathan James
Ferguson, James Edward, III
Huang, He
Dadhania, Vipulkumar
Gao, Jianjun
Dinney, Colin
Weinstein, John N.
Baggerly, Keith
McConkey, David
Czerniak, Bogdan
CELL REPORTS, 2019, 27 (06): : 1781 - +
[26] KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
Qiu, Hong
Makarov, Vladimir
Bolzenius, Jennifer K.
Halstead, Angela
Parker, Yvonne
Wang, Allen
Iyer, Gopakumar V.
Wise, Hannah
Kim, Daniel
Thayaparan, Varna
Lindner, Daniel J.
Haber, Georges-Pascal
Ting, Angela H.
Ren, Bing
Chan, Timothy A.
Arora, Vivek
Solit, David B.
Lee, Byron H.
CANCER RESEARCH, 2023, 83 (06) : 814 - 829
[27] Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer
Sun, Ming
Zhao, Wenyan
Xie, Qingpeng
Zhan, Yunhong
Wu, Bin
SURGICAL ONCOLOGY-OXFORD, 2015, 24 (01): : 28 - 34
[28] LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
Pei, Lu
Yan, Dong
He, Qingqing
Kong, Jianqiu
Yang, Meihua
Ruan, Honglian
Lin, Qiongqiong
Huang, Lifang
Huang, Jian
Lin, Tianxin
Qin, Haide
CELLULAR ONCOLOGY, 2023, 46 (05) : 1509 - 1527
[29] LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
Lu Pei
Dong Yan
Qingqing He
Jianqiu Kong
Meihua Yang
Honglian Ruan
Qiongqiong Lin
Lifang Huang
Jian Huang
Tianxin Lin
Haide Qin
Cellular Oncology, 2023, 46 : 1509 - 1527
[30] MYELOPEROXIDASE IMPACTS LUNG CANCER CELLS AND DRIVES TUMOR PROGRESSION IN NON-SMALL CELL LUNG CANCER
Mujkanovic, Nejra Cosic
Valadez-Cosmes, Paulina
Maitz, Kathrin
Lueger, Anna
Kindler, Oliver
Marsche, Gunther
Kargl, Julia
FREE RADICAL BIOLOGY AND MEDICINE, 2023, 201 : 53 - 53

← 1 2 3 4 5 →